The BioStem Life Sciences Focus

BioStem is focused on harnessing the power of regenerative biologics by creating cellular medicine as a new paradigm of healthcare using breakthrough therapies that treat patients who otherwise are without effective treatment options. Our emphases will be advancing ethical regenerative medical treatments for muscular, joint, neurodegenerative and autoimmune diseases that benefit our society.

The Benefits of Regenerative Medicine

Regenerative Biologics contain the ability to generate replacements for cells that are lost through normal wear and tear, injury, or disease. As a multi-potent cell, they have the potential to develop into different cell types in the body. When a stem cell divides, each new cell can remain a multi-potent stem cell, or develop into a more differentiated type of cell, such as a muscle cell, red blood cell, or a brain cell. They have also been shown to produce a signal to induce changes in nearby cells further promoting repair and regeneration in surrounding tissue. Regenerative biologic research continues to advance exponentially each year and is one of the most fascinating and investable areas of medicine today.

Patient Testimonial

Having exhausted all current treatment options, many of our patients come to us seeking alternative options. Educating them on the remarkable potential of the body’s own natural repair mechanisms, and the demonstrated effectiveness of adult stem cell therapy, we grant our patients access to treatment for certain chronic conditions.

The Current State Of the Market Regenerative Medicine Market

The state of Regenerative Medicine today in the U.S. medical community is highly fragmented due to lack of FDA regulation and guidance. This absence has created a climate of boldness opening the door for some profit seekers to exploit the public with dubious claims and treatments. 


  • Crowded with non approved and non regulated providers and treatments. 

  • Highly fragmented information within the medical communities as well as spotty patient education.

  • The FDA is threatening intervention on various unapproved clinics that use questionable advertising and unapproved treatments. 

  • Public skepticism of treatment due to the varying levels of results and performance (Age/Concentration/No Growth Factors/No Extra Cellular Matrix. Variable Outcomes with these therapies.

  • Many U.S. based clinics have obtained cells from Bone Marrow, Fat, Platelet Rich Plasma (PRP) and either misunderstand or are misrepresenting treatment claims to patients. 

The Future of Regenerative Medicine

The future of the Regenerative Medicine field is very bright! The FDA has publicly stated that it will provide formal regulatory oversight and guidance to the Regenerative Medicine industry within the next 24 months providing clear standards for open market treatment utilizing regenerative biologics that are derived from stem cell products and therapies.

The BioStem team is dedicated to addressing all concerns brought up by both the FDA and other reputable medical practitioners by working in concert with the FDA and other regulatory authorities to define new standards that will normalize and properly regulate the industry. We are developing regenerative biologics using proven clinical and pharmaceutical developmental pathways that will bring regenerative biologics to the market as a drug for practitioners to administer. This approach eliminates questionable “back room” approaches seen in the current medical tourism market both in and outside the U.S.

Understanding Stem Cells

Our Strategy for the Future

BioStem is already working to develop a wide array of biologic stem cell based alternative products that can easily be administered by practitioners as an off-the-shelf drug or treatment for ailments such as joint pain, tendon and ligament injuries, neurodegenerative and autoimmune diseases. To accomplish this BioStem has recruited some of the top scientists in the regenerative medicine field to work in our state of the art research, development, and manufacturing facilities with a goal to produce the next generation FDA approved regenerative drugs and therapies.   

No claims as to expected benefits or outcomes are made by BioStem Technologies.